---
pmid: '25613181'
title: MMP-2 inhibits PCSK9-induced degradation of the LDL receptor in Hepa1-c1c7
  cells.
authors:
- Wang X
- Berry E
- Hernandez-Anzaldo S
- Sun D
- Adijiang A
- Li L
- Zhang D
- Fernandez-Patron C
journal: FEBS Lett
year: '2015'
full_text_available: false
doi: 10.1016/j.febslet.2015.01.007
---

# MMP-2 inhibits PCSK9-induced degradation of the LDL receptor in Hepa1-c1c7 cells.
**Authors:** Wang X, Berry E, Hernandez-Anzaldo S, Sun D, Adijiang A, Li L, Zhang D, Fernandez-Patron C
**Journal:** FEBS Lett (2015)
**DOI:** [10.1016/j.febslet.2015.01.007](https://doi.org/10.1016/j.febslet.2015.01.007)

## Abstract

1. FEBS Lett. 2015 Feb 13;589(4):490-6. doi: 10.1016/j.febslet.2015.01.007. Epub 
2015 Jan 19.

MMP-2 inhibits PCSK9-induced degradation of the LDL receptor in Hepa1-c1c7 
cells.

Wang X(1), Berry E(1), Hernandez-Anzaldo S(1), Sun D(2), Adijiang A(3), Li L(2), 
Zhang D(4), Fernandez-Patron C(5).

Author information:
(1)Department of Biochemistry, University of Alberta, Edmonton, Alberta, Canada; 
Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, 
Canada.
(2)Department of Chemistry, University of Alberta, Edmonton, Alberta, Canada; 
Faculty of Science, University of Alberta, Edmonton, Alberta, Canada.
(3)Group on Molecular and Cell Biology of Lipids, University of Alberta, 
Edmonton, Alberta, Canada; Faculty of Medicine and Dentistry, University of 
Alberta, Edmonton, Alberta, Canada.
(4)Department of Biochemistry, University of Alberta, Edmonton, Alberta, Canada; 
Group on Molecular and Cell Biology of Lipids, University of Alberta, Edmonton, 
Alberta, Canada; Faculty of Medicine and Dentistry, University of Alberta, 
Edmonton, Alberta, Canada.
(5)Department of Biochemistry, University of Alberta, Edmonton, Alberta, Canada; 
Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, 
Canada; Cardiovascular Research Group, University of Alberta, Edmonton, Alberta, 
Canada; Faculty of Medicine and Dentistry, University of Alberta, Edmonton, 
Alberta, Canada. Electronic address: cf2@ualberta.ca.

Low-density lipoprotein receptor (LDLR) catalyzes the uptake of LDL-cholesterol 
by liver and peripheral organs. The function of the LDLR is antagonized by 
pro-protein convertase subtilisin/kexin type 9 (PCSK9), which binds to LDLR at 
the plasma membrane inducing LDLR degradation. Here, we report that matrix 
metalloproteinase-2 (MMP-2) interacts with and cleaves PCSK9, as evidenced by 
proteomic, chemical cross-linkage, blue native-PAGE and domain-specific 
antibodies Western blot analyses. Furthermore, MMP-2 overexpression renders 
Hepa1-c1c7 cells resistant to PCSK9-induced LDLR degradation. The data suggest 
that pathological MMP-2 overexpression may protect the LDLR from PCSK-9-induced 
degradation.

Copyright Â© 2015 Federation of European Biochemical Societies. Published by 
Elsevier B.V. All rights reserved.

DOI: 10.1016/j.febslet.2015.01.007
PMID: 25613181 [Indexed for MEDLINE]
